Use of haematopoietic cell transplantation (HCT) in the treatment of haematologic and
neoplastic diseases may lead to life‐threatening complications that cause substantial …

JCM | Free Full-Text | Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A
Review Based on Physiopathology Next Article in Journal Obesity, Inflammation, and Mortality …

Transplantation-associated thrombotic microangiopathy (TA-TMA) is an increasingly
recognized complication of hematopoietic cell transplantation (HCT) associated with …

Transplant-associated thrombotic microangiopathy (TA-TMA) is a form of microangiopathy
specifically occurring in the context of hematopoietic stem cell transplantation. Similarly, to …

Transplant-associated thrombotic microangiopathy (TA-TMA) is a well-recognized
complication of hematopoietic cell transplantation (HCT). Diagnosis is challenging and in …

Allogeneic hematopoietic stem cell transplantation (HSCT) is an established treatment with
curative intent for hematologic malignancies and several nonmalignant conditions …

Objective To evaluate response rates and survival in adults with transplant‐associated
thrombotic microangiopathy (TA‐TMA) after allogeneic hematopoietic stem cell …

To identify plasma biomarkers associated with fibrotic mechanisms of chronic graft-versus-
host disease (GVHD), we used multiplex mass spectrometry with pooled samples for …

Hematologic malignancies are the main clinical indications for allogeneic hematopoietic
stem cell transplantation (HSCT). In previous years, the evolution of this procedure …

Objective This study aimed to evaluate the effectiveness of Ruxolitinib for acute/chronic graft-
versus-host disease in children. Methods This study was a retrospective trial. We analyzed …